Physician profile
Carlos Echevarria
NPI 1538425558
$14,040.63
in general payments reported to CMS, 2019-2025
13 companies · $895 in 2025
The $895 reported for 2025 was more than what 86% of Phlebology providers received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2023: $13K · 2024: $56.62 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $13K · Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,500.00 |
| Food and Beverage | $1,296.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,500.00 | 2023 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $276.61 | 2019-2023 | Varithena Administration Pack |
| Tactile Systems Technology INC | $260.81 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Medtronic, INC. | $238.90 | 2023-2025 | Venaseal |
| Bard Peripheral Vascular, INC. | $221.01 | 2025 | Rotarexs 6 F X 135 Cm, Bard Marquee |
| Inspire Medical Systems, INC. | $144.67 | 2025 | Inspire |
| Amgen INC. | $142.91 | 2025 | |
| Stemline Therapeutics INC. | $142.23 | 2025 | Orserdu |
| Flowphysix INC | $30.50 | 2025 | Flowrunner |
| Corcept Therapeutics | $24.04 | 2025 | Korlym |
| Abbott Laboratories | $23.94 | 2023 | Ionicrf |
| Ge Healthcare | $17.90 | 2024 | |
| Philips North America LLC | $17.11 | 2024 | (Bs0) Mechanical Atherectomy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Echevarria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.